• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?在现代，局部晚期非小细胞肺癌放疗时能否省略临床靶区？
Transl Lung Cancer Res. 2021 Jan;10(1):5-8. doi: 10.21037/tlcr-2020-19.
2
Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique.临床靶区是否必要？——采用调强放疗技术同步放化疗治疗局部晚期非小细胞肺癌患者的失败模式分析
Transl Lung Cancer Res. 2020 Oct;9(5):1986-1995. doi: 10.21037/tlcr-20-523.
3
Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy.不可切除的局部晚期非小细胞肺癌的放射治疗：免疫治疗时代的现状与未来前景述评
Transl Lung Cancer Res. 2020 Oct;9(5):2097-2112. doi: 10.21037/tlcr-20-511.
4
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.基于影像学的局部晚期非小细胞肺癌放化疗靶区缩小（PET-Plan）：一项多中心、开放标签、随机、对照试验。
Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12.
5
Impact of modern radiotherapy techniques on survival outcomes for unselected patients with large volume non-small cell lung cancer.现代放疗技术对未经选择的大体积非小细胞肺癌患者生存结局的影响。
Br J Radiol. 2019 Mar;92(1095):20180928. doi: 10.1259/bjr.20180928. Epub 2018 Nov 29.
6
Evolving target volume concepts in locally advanced non-small cell lung cancer.局部晚期非小细胞肺癌中不断演变的靶区概念
Transl Lung Cancer Res. 2021 Apr;10(4):1999-2010. doi: 10.21037/tlcr-20-805.
7
Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report.适形调强图像引导下的中等分割胸部放疗用于肺功能非常有限的局部晚期淋巴结阳性非小细胞肺癌患者：一例报告
Radiat Oncol J. 2017 Jun;35(2):180-184. doi: 10.3857/roj.2017.00129. Epub 2017 Jun 30.
8
Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.容积调强弧形治疗降低局部晚期非小细胞肺癌放疗中≥2 级放射性肺炎发生率的潜在获益。
Jpn J Clin Oncol. 2021 Dec 1;51(12):1729-1735. doi: 10.1093/jjco/hyab163.
9
New radiotherapy approaches in locally advanced non-small cell lung cancer.局部晚期非小细胞肺癌的新放疗方法。
Eur J Cancer. 2014 Feb;50(3):525-34. doi: 10.1016/j.ejca.2013.11.027. Epub 2013 Dec 12.
10
Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery.比较放疗或手术治疗局部晚期非小细胞肺癌患者早期放射性肺炎的风险和预测因素。
Lung Cancer. 2014 Dec;86(3):329-33. doi: 10.1016/j.lungcan.2014.10.005. Epub 2014 Oct 17.

引用本文的文献

1
Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis.癌症放射治疗联合免疫治疗的全球研究格局与趋势：一项文献计量分析。
Heliyon. 2024 Feb 27;10(5):e27103. doi: 10.1016/j.heliyon.2024.e27103. eCollection 2024 Mar 15.

本文引用的文献

1
Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique.临床靶区是否必要？——采用调强放疗技术同步放化疗治疗局部晚期非小细胞肺癌患者的失败模式分析
Transl Lung Cancer Res. 2020 Oct;9(5):1986-1995. doi: 10.21037/tlcr-20-523.
2
Use of Multi-Site Radiation Therapy for Systemic Disease Control.使用多部位放射治疗控制全身性疾病
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):352-364. doi: 10.1016/j.ijrobp.2020.08.025. Epub 2020 Aug 13.
3
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.肺癌患者接受免疫联合放疗时，淋巴细胞减少症、放疗技术、剂量学与生存结局的相互作用。
Radiother Oncol. 2020 Sep;150:114-120. doi: 10.1016/j.radonc.2020.05.051. Epub 2020 Jun 7.
4
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials.绝对淋巴细胞计数可预测接受免疫联合放疗患者的远隔效应和结局：3 项 1/2 期试验分析。
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):196-203. doi: 10.1016/j.ijrobp.2020.01.032. Epub 2020 Feb 7.
5
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.NRG肿瘤学RTOG 0617的长期结果：不可切除的III期非小细胞肺癌采用标准剂量与高剂量放化疗联合或不联合西妥昔单抗的疗效对比
J Clin Oncol. 2020 Mar 1;38(7):706-714. doi: 10.1200/JCO.19.01162. Epub 2019 Dec 16.
6
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
7
Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.使用 PET 和其他功能成像来指导放射肿瘤学中的靶区勾画。
Semin Radiat Oncol. 2018 Jun;28(3):171-177. doi: 10.1016/j.semradonc.2018.02.001.
8
Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer.非小细胞肺癌中排除选择性淋巴结照射与最小的选择性淋巴结失败相关。
Radiat Oncol. 2009 Jan 30;4:5. doi: 10.1186/1748-717X-4-5.
9
Involved-field radiation therapy for inoperable non small-cell lung cancer.不可切除非小细胞肺癌的累及野放射治疗
J Clin Oncol. 2007 Dec 10;25(35):5557-61. doi: 10.1200/JCO.2007.13.2191. Epub 2007 Nov 5.
10
A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.一项关于局部野照射与选择性淋巴结照射联合同步化疗用于不可切除的Ⅲ期非小细胞肺癌的随机研究。
Am J Clin Oncol. 2007 Jun;30(3):239-44. doi: 10.1097/01.coc.0000256691.27796.24.

Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?

作者信息

Verma Vivek, Chang Joe Y

机构信息

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Transl Lung Cancer Res. 2021 Jan;10(1):5-8. doi: 10.21037/tlcr-2020-19.

DOI:10.21037/tlcr-2020-19
PMID:33569287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867789/
Abstract
摘要